Search results
Moderna says FDA delayed RSV vaccine approval to end of May
CNBC· 5 days agoModerna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 5 days agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 7 hours agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 5 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 5 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoProofPilot, the industry's premier platform for patient & site automation, guidance, and seamless execution, announces today its double victory alongside esteemed partner Moderna< ...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 2 days agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 3 days agoWealthspire Advisors LLC trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities ...
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Russell Investments Group Ltd.
ETF DAILY NEWS· 6 days agoRussell Investments Group Ltd. cut its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 28.3% during the 4th quarter, according to its most recent Form 13F ...
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 2 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. Following ...